These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4302048)

  • 41. [Disc electrophoretic analysis of cerebrospinal fluid proteins in the disturbances of optic nerve. I. Comparison of cerebrospinal fluid at various sites in the cerebrospinal axis. With special reference to the cerebrospinal fluid in the chiasmatic cistern].
    Tagami T
    Nippon Ganka Gakkai Zasshi; 1970 Sep; 74(9):1129-35. PubMed ID: 4319589
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnosis of subacute and chronic virus infections of the CNS using cerebrospinal fluid protein electrophoresis].
    Siemes H; Siegert M; Hanefeld F
    Monatsschr Kinderheilkd (1902); 1980 May; 128(5):250-2. PubMed ID: 7421827
    [No Abstract]   [Full Text] [Related]  

  • 43. [Proteins in the cerebrospinal fluid in patients with cerebrovascular diseases: determination by Lowry's method].
    Kotoku T; Izumi N; Ito K
    Rinsho Byori; 1972 Apr; 20(4):274-8. PubMed ID: 5066525
    [No Abstract]   [Full Text] [Related]  

  • 44. Carcinoembryonic antigen in cerebrospinal fluid of adult brain-tumor patients.
    Hill S; Martin E; Ellison EC; Hunt WE
    J Neurosurg; 1980 Nov; 53(5):627-32. PubMed ID: 7431072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis of various proteins of CSF of the central nervous diseases. (3) Comparative analytic studies of the CSF proteins between the spinal and the intracranial subarachnoidal space (author's transl)].
    Eno N; Nakajima T; Watanabe N; Tajino M
    Nippon Ganka Gakkai Zasshi; 1978 Dec; 82(12):862-5. PubMed ID: 83787
    [No Abstract]   [Full Text] [Related]  

  • 46. [Analysis of various proteins of CSF on the central nervous diseases. (1) The quantitative method of alpha1-AGP in CSF and the tendency of alpha1-AGP's value on some central nervous diseases (author's transl)].
    Eno N; Watanabe N; Nakajima T; Tajino M
    Nippon Ganka Gakkai Zasshi; 1977 Jun; 81(6):550-4. PubMed ID: 906943
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cerebrospinal fluid G immunoglobulins in nervous system diseases].
    Livramento JA; Melaragno Filho R; Spina-França A
    Arq Neuropsiquiatr; 1981 Jun; 39(2):156-61. PubMed ID: 7283797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinico-diagnostic value of cerebrospinal fluid activity in brain tumors and disorders of the cerebrovascular circulation].
    Popel'nitskaia IV
    Vrach Delo; 1966 Jan; 1():129-30. PubMed ID: 5974035
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical cerebrospinal fluid diagnostics].
    Delank HW
    Nervenarzt; 1972 Feb; 43(2):57-68. PubMed ID: 4622639
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diagnostic assessment of cerebrospinal fluid protein in brain and spinal tumors].
    Kuppe G; Schmidt RM
    Psychiatr Neurol Med Psychol (Leipz); 1987 Oct; 39(10):613-7. PubMed ID: 3432440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cytomorphological studies on the cerebrospinal fluid in healthy dogs and in 7 cases with central nervous system diseases].
    Schmidt U; Hübner S
    Zentralbl Veterinarmed A; 1974 Feb; 21(2):157-64. PubMed ID: 4211375
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunoelectrophoretic abnormalities in the anodic field of the IgG precipitation arc during central nervous system disorders.
    Kolár O; Zeman W
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):408-16. PubMed ID: 4177443
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the C-reactive protein in the cerebrospinal fluid].
    Cicvárek Z; Orolin D
    Psychiatr Neurol Med Psychol (Leipz); 1968 Apr; 20(4):144-7. PubMed ID: 5731865
    [No Abstract]   [Full Text] [Related]  

  • 54. [Interest in the cytological study of cerebrospinal fluid in malignant central nervous system tumors].
    Mazalton A; Le Beau J
    Neurochirurgia (Stuttg); 1970 Nov; 13(6):219-27. PubMed ID: 4321511
    [No Abstract]   [Full Text] [Related]  

  • 55. [Fibrinogen in the cerebrospinal fluid. Micro-immunoelectrophoretic study].
    De Zanche L; Tavolato B
    Boll Soc Ital Biol Sper; 1966 Sep; 42(18):1240-4. PubMed ID: 4165851
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cerebrospinal fluid syndromes in stroke].
    Lobkova TN
    Sov Med; 1982; (4):22-5. PubMed ID: 7101052
    [No Abstract]   [Full Text] [Related]  

  • 57. [The C.S.F. protein formula in central nervous system diseases and especially in multiple sclerosis. Study of 218 examinations].
    Bizouard P; Guisard D; André JM; Arnould G
    Sem Hop; 1970 Jul; 46(31):2151-62. PubMed ID: 4195397
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cytodiagnosis of cerebrospinal fluid].
    Möbius W
    Verh Dtsch Ges Inn Med; 1972; 78():298-301. PubMed ID: 4665664
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the total protein-bound polysaccharide hexose (PBP) of cerebrospinal fluid in the neuropsychiatric field. III. Survey in general paresis, brain tumor and other diseases of central nervous system.
    SAKURADA S; TANAKA Z; SAKURADA T
    Folia Psychiatr Neurol Jpn; 1960 Jul; 14():167-77. PubMed ID: 13745510
    [No Abstract]   [Full Text] [Related]  

  • 60. The determination of transaminase activity in cerebro-spinal fluid. A study of 192 cases of cerebrovascular lesions and of 50 tumors of the brain.
    FAZIO C; FIESCHI C; SORIANI S
    Confin Neurol; 1961; 21():326-44. PubMed ID: 13891908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.